Lataa...
The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors
The clinical use of EGFR-targeted therapy, in triple negative breast cancer patients, has been limited by the development of resistance to these drugs. Although activated signaling molecules contribute to this process, the molecular mechanisms remain relatively unknown. We have previously reported t...
Tallennettuna:
| Julkaisussa: | Cancer Biol Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4846185/ https://ncbi.nlm.nih.gov/pubmed/26176330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1071737 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|